Author finds Herbal Dispatch's growth decent but rejects the stock due to poor margins, thin balance sheet, and operating losses.
Unpriced research observations (excluded from Calls and Returns):
HERB — AVOID Herbal Dispatch shows decent growth but has poor margins, a very thin balance sheet, and operates at a loss. The author is not interested in investing because of these weak fundamentals. resolved_asset_type_mismatch
Decent growth but nothing else. Margins are poor, balance sheet is very thin, operating at a loss. Not interested